CompletedNot Applicable

Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France

France777 participantsStarted 2015-06-16

Plain-language summary

The purpose of the study is to describe the characteristics and management of post menopausal women with osteoporosis treated with Prolia in France, and examine the use of Prolia in routine clinical practice in France

Who can participate

Age range40 Years – 95 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * post menopausal osteoporosis women in whom a decision has been made to treat with Prolia in the last 4 weeks * received their first prescription of Prolia in the last 4 weeks * patient has provided informed consent before enrolling in the study Exclusion Criteria: * patients participating in ongoing or previous Denosumab clinical trials

What they're measuring

patient occurence of persistence (persistence is defined in the outcome description) at 12 months

Timeframe: 12 months

Trial details

NCT IDNCT02347865

SponsorAmgen

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2017-10-26

View on ClinicalTrials.gov More Post Menopausal Osteoporosis trials